Authors: E S Kuzina A A Kudriaeva D V Maltseva A A Belogurov
Publish Date: 2016/06/06
Volume: 161, Issue: 1, Pages: 69-71
Abstract
We studied the effect of β1ispecific peptidyl aldehyde IPSI001 on proteasome from mammalian cells In concentrations 1 μM this agent effectively suppressed immunoproteasome but only slightly reduced chymotrypsinlike activity of constitutive proteasome Intraperitoneal administration of this inhibitor to C3H/He mice in a dose of 100 mg/kg induced no significant physiological or behavioral changes which attested to its considerable therapeutic potential in the treatment of autoimmune neurodegenerative pathologies
Keywords: